Greg Simon (Simonovation LLC) and Christopher Austin (Vesalius Therapeutics) discuss keys for accelerating the development of treatments and cures for appendiceal cancer and other rare diseases. This session kicked off a workshop on "New Approaches to Accelerating Biomedical Innovation: Case Study on Appendiceal Cancer" held at MIT on April 11-12, 2023, and co-hosted by MIT's Laboratory for Financial Engineering and Koch Institute for Integrative Cancer Research.

*The views and opinions expressed in this video are those of the speaker only and do NOT represent the views and opinions of Simonovation LLC, Vesalius Therapeutics, MIT, any of their affiliates or employees, or any of the workshop organizers or participants.*